Skip to main content

Silexion Therapeutics Corp 8-K, filed Nov 12, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on November 12, 2026.

Silexion Therapeutics Corp completed a 1-for-24 reverse share split effective after trading on November 10, 2026, leaving 21,495,833 authorized ordinary shares at $3.24 par value and adjusting warrants to 1/24 share each at $372,600.00 per share. AI summary

Items reported

  • Item 3.03: Change to shareholders' rights
  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits